Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Dermatitis, Atopic Clinical Trials

A listing of Dermatitis, Atopic medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (8) clinical trials

This is a double-blind, randomized, placebo-controlled study to assess the efficacy & safety of tradipitant in reducing chronic pruritus (itching) in adults with atopic dermatitis (eczema). All enrolled subjects will receive oral medication to be taken twice daily for 8 weeks. There are 6 office visits throughout the study which ...

Phase

About the investigational drug The investigational drug is called GBR 830. By targeting cells that cause inflammation, it is hoped that treatment with this investigational drug may help improve symptoms and reduce reliance on topical medications.   Who will be joining the study? Approximately 392 people with eczema will enroll ...

Phase

This is a double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of Tralokinumab for the treatment of moderate to severe Atopic Dermatitis. All enrolled participants will receive subcutaneous injections of medication every two weeks for 52 weeks. There are 16 in-office visits throughout the study and ...

Phase

This is a multicenter double-blind, randomized, placebo-controlled study to assess the efficacy and safety of IDP-124 lotion for the treatment of moderate to severe atopic dermatitis (eczema). All enrolled subjects will receive a lotion medication to be applied twice daily for 6 weeks. There are 7 office visits throughout the ...

Phase

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Fifteen subjects with moderate to severe AD will receive dupilumab for a treatment period of 52 weeks (i.e. last injection on week 50). Biopsy samples from AD subjects and surgical discard samples will undergo molecular profiling. Skin swabs and stool samples will be collected and banked for future analysis. The ...

Phase

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

B7451029 is a Phase 3 study to investigate PF-04965842 in adult patients who have moderate to severe atopic dermatitis and use background topical therapy. The efficacy of two dosage strengths of PF-04965842, 100 mg and 200 mg taken orally once daily will be evaluated relative to placebo over 12 weeks. ...

Phase

A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

This will be a randomized, double-blind, placebo-controlled clinical study with dose escalations to assess safety, tolerability, and pharmacodynamic effect of EDP1815. Since this clinical study is the first study in humans, the participants will be healthy volunteers or subjects with mild to moderate psoriasis or atopic dermatitis who are otherwise ...

Phase

Eczema Reminder and Accountability Program

Eczema is a chronic disease that requires long term and extensive treatment. However patient adherence to the treatment plans provided to them by their healthcare providers is poor. Frequent follow-up appointments have been demonstrated to improve treatment adherence, this may be due to patients feeling a sense of accountability which ...

Phase N/A